Cancer Clinical Trial
— SHUTi-COfficial title:
Evaluating Internet-Based Interventions for Insomnia in Cancer Patients
Verified date | February 2010 |
Source | University of Virginia |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Institutional Review Board |
Study type | Interventional |
The purpose of this study is to determine whether an Internet-based program, Sleep Healthy Using the Internet (SHUTi, or "Shut-Eye"), can help to improve the sleep of people who are in remission from cancer and experiencing symptoms of insomnia.
Status | Completed |
Enrollment | 22 |
Est. completion date | November 2009 |
Est. primary completion date | November 2009 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 21 Years and older |
Eligibility |
Inclusion Criteria: - Age = At least 21 years old - Regular access to the Internet, including e-mail - Cancer patient - Any type of cancer (EXCEPT non-melanoma skin cancer) - In remission from any stage of cancer (active treatment completed at least one month prior to enrollment) - Insomnia diagnosis (combined from DSM-IV and ICSD): - Subjective complaints of poor sleep for at least 6 months - Sleep difficulties =3 nights/week - Difficulty falling asleep (=30 minutes to fall asleep) OR - Difficulty staying asleep (=30 minutes awake in the middle of the night) - =6.5 hours sleep/night - Poor sleep causes marked distress or significant impairment in daytime functioning (e.g. fatigue, performance deficits, mood disturbance) - Participant feels that the insomnia was caused/aggravated by cancer or cancer treatment Exclusion Criteria: - Having a sleep disorder other than insomnia (e.g. sleep apnea, RLS, narcolepsy, parasomnias) - Having a medical condition other than cancer that causes insomnia - Experiencing a psychiatric disturbance (major depression, psychosis) - Experiencing substance abuse - Currently undergoing psychotherapy or counseling - Changing sleep/anxiety/depression medication within the past month - Having an "unusual" sleep pattern - Normal bedtime is after 2am OR - Normal wake time is after 9am - Working as a shift worker (that is, having a schedule that requires working through the night) - Participants reports that she is pregnant or intending to get pregnant in the next 4 months |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
United States | University of Virginia Department of Psychiatry & Neurobehavioral Sciences | Charlottesville | Virginia |
Lead Sponsor | Collaborator |
---|---|
University of Virginia |
United States,
Savard J, Simard S, Ivers H, Morin CM. Randomized study on the efficacy of cognitive-behavioral therapy for insomnia secondary to breast cancer, part I: Sleep and psychological effects. J Clin Oncol. 2005 Sep 1;23(25):6083-96. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Insomnia Severity Index (ISI) | prior to intervention, after SHUTi use, after Hypnosis use | No | |
Primary | Sleep Diary: Sleep Efficiency | prior to intervention, after SHUTi use, after Hypnosis use | No | |
Primary | Sleep Diary: Total Sleep Time | prior to intervention, after SHUTi use, after Hypnosis use | No | |
Secondary | Sleep Diary: Sleep Onset Latency (SOL) | prior to intervention, after SHUTi use, after Hypnosis use | No | |
Secondary | Sleep Diary: Wake After Sleep Onset (WASO) | prior to intervention, after SHUTi use, after Hypnosis use | No | |
Secondary | Sleep Diary: Number of Nighttime Awakenings | prior to intervention, after SHUTi use, after Hypnosis use | No | |
Secondary | Hospital Depression and Anxiety Scale | prior to intervention, after SHUTi use, after Hypnosis use | No | |
Secondary | Pain scale | prior to intervention, after SHUTi use, after Hypnosis use | No | |
Secondary | Multidimensional Fatigue Symptom Inventory | prior to intervention, after SHUTi use, after Hypnosis use | No | |
Secondary | Quality of Life (SF-12 Health Survey) | prior to intervention, after SHUTi use, after Hypnosis use | No | |
Secondary | Hot flashes | prior to intervention, after SHUTi use, after Hypnosis use | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05346796 -
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
|
N/A | |
Recruiting |
NCT05094804 -
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
|
Phase 1/Phase 2 | |
Completed |
NCT04867850 -
Effect of Behavioral Nudges on Serious Illness Conversation Documentation
|
N/A | |
Enrolling by invitation |
NCT04086251 -
Remote Electronic Patient Monitoring in Oncology Patients
|
N/A | |
Completed |
NCT01285037 -
A Study of LY2801653 in Advanced Cancer
|
Phase 1 | |
Completed |
NCT00680992 -
Study of Denosumab in Subjects With Giant Cell Tumor of Bone
|
Phase 2 | |
Completed |
NCT00062842 -
Study of Irinotecan on a Weekly Schedule in Children
|
Phase 1 | |
Active, not recruiting |
NCT04548063 -
Consent Forms in Cancer Research: Examining the Effect of Length on Readability
|
N/A | |
Completed |
NCT04337203 -
Shared Healthcare Actions and Reflections Electronic Systems in Survivorship
|
N/A | |
Recruiting |
NCT04349293 -
Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways
|
N/A | |
Terminated |
NCT02866851 -
Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy
|
N/A | |
Active, not recruiting |
NCT05304988 -
Development and Validation of the EFT for Adolescents With Cancer
|
||
Completed |
NCT04448041 -
CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
|
||
Completed |
NCT00340522 -
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
|
||
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Active, not recruiting |
NCT03844048 -
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
|
Phase 3 | |
Completed |
NCT03109041 -
Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source
|
Phase 1 | |
Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
Terminated |
NCT01441115 -
ECI301 and Radiation for Advanced or Metastatic Cancer
|
Phase 1 | |
Recruiting |
NCT06206785 -
Resting Energy Expenditure in Palliative Cancer Patients
|